Dr. Greg Vigna

Coloplast Corporation was hit with a lawsuit filed by a woman who sustained injuries caused by Ariis mid-urethral sling. Dr. Greg Vigna discusses the details.

SANTA BARBARA, CALIFORNIA, UNITED STATES, August 18, 2021 /EINPresswire.com/ -- On August 17, 2021 Coloplast Corporation was hit with a lawsuit filed by a woman who sustained injuries caused by the Ariis mid-urethral sling used for the treatment of stress urinary incontinence (SUI). The lawsuit was filed in the U.S. District Court for the Central District of California Southern Division (Case 8:21-cv-01358).

The Plaintiff is represented by Ben C. Martin and Laura Baughman of Martin Baughman, PLLC and Greg Vigna, MD, JD. Ben Martin and Laura Baughman are national pharmaceutical injury attorneys in Dallas, Texas. Dr. Vigna is a California and Washington DC lawyer who focuses on catastrophic injuries and the neurological injuries caused by transvaginal mesh devices including pudendal neuralgia, obturator neuralgia, and complex regional pain syndrome.

Dr. Greg Vigna, practicing physician, national pharmaceutical injury attorney, and certified life care planner states, “We are filing cases on behalf of severely injured women suffering from disabling pain caused by the transvaginal mesh polypropylene devices used for the treatment of pelvic organ prolapse (POP) and mid-urethral slings used for the treatment of stress urinary incontinence (SUI) across the country at about one case a week. These are valuable cases in understanding that future care cost for pudendal and obturator neuralgia is about $400,000-$700,000 per decade of life remaining. That number doesn’t include lost wages, pain and suffering, and the potential for punitive damages as Coloplast, Ethicon, and Boston Scientific.”

Dr. Vigna's observations includes, “As a practicing inpatient rehabilitation physician I have had the privilege of my life-time caring for patients with spinal cord injury related pain syndromes, RSD, and phantom pain after amputation. The pain syndromes caused by polypropylene mid-urethral slings appear to be far worse than those.”

The Vigna Law Group targets the below transobturator (TOT) slings and mini-slings that cause pudendal and obturator neuralgia:

Ethicon: TVT-O, Abbrevo
Boston Scientific: Obtryx, Solyx
Coloplast: Aris, Altis

The Vigna Law Group targets the below retropubic slings that cause ilioinguinal neuralgia, pudendal neuralgia, and Complex Regional Pain Syndrome:

Ethicon: TVT, TVT-Exact
Boston Scientific: Advantage Fit, Lynx
Coloplast: Supris

The Vigna Law Group is evaluating pelvic organ prolapse TVM cases that have been dismissed without prejudice from the MDL and latent injuries caused by the POP devices including Prolift, Avaulta, Pinnacle, Restorelle Direct Fix, and the Uphold device.

To learn more on the anatomical basis for TOT complications including obturator and pudendal neuralgia and the treatments of obturator and pudendal neuralgia visit: https://vignalawgroup.com/ebooks/pelvic-mesh-pain/#page=59

Download a FREE BOOK on Vaginal Mesh Pain
For articles, video resources, and information visit the Pudendal Neuralgia Educational Portal or https://tvm.lifecare123.com/.
Visit our website for information regarding sling related complications: https://tvm.lifecare123.com/slingebook.html
Click here to listen to Dr. Vigna and national pharmaceutical injury attorney Laura Baughman and Ben Martin.

Greg Vigna, MD, JD
Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA
1-800-761-9206

Greg Vigna, M.D., J.D., Certified Life Care Planner
Academic Physician Life Care Planning
6619100229 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.